Still, the reply to your e-mail is not definitive in that the name of the manufacturer is not given. It is apparent that it's not Oasis Pharmaceutical, probably a defunct company by now. With limited resources (ie. CASH) they must negotiate reasonable terms with the manufacturer. It is also apparent that their relationship with the Hensleys is finished. No results on their marketing end substantiates my conclusion. The only major position, at this point, is if the receive the MYECheck mobile payment app/back end processor. That would initiate major business for the company and a significant rise in ITNS PPS. However, examining the day to day trades, it looks like many shareholders have lost patience with the lack of news and past failures. The 3Q'15 (8/31/15) financials are due soon. Time will tell!
News 
Market Data 
Discover 
